Policy letters and testimony

The PAN Foundation provided public testimony to the Advisory Panel on Outreach and Education for the Centers for Medicare and Medicaid Services (CMS) on two key Medicare reforms, the Part D $2,000 cap on out-of-pocket expenses for prescription medications (effective in 2025) and the Medicare Prescription Payment Plan (currently in effect). In this letter, PAN calls for increased outreach and education to Medicare beneficiaries about these two reforms.

PAN submitted a statement on record to the U.S. House Energy and Commerce Committee, urging the committee to make current Medicare telehealth access permanent and to address payment and regulatory barriers that limit access to telehealth. In this testimony, PAN supported the CONNECT for Health Act (H.R. 4189), Telehealth Modernization Act (H.R. 7623), and the Telemental Health Care Access Act (H.R. 3432).

In a letter with the Alliance for Connected Care, 214 allies from telehealth service providers and patient advocacy organizations, PAN urged the US Drug Enforcement Administration (DEA) to make telehealth access permanent. Telemedicine flexibilities would allow healthcare providers to continue to prescribe medications for mental health care and substance use disorder treatment.

The PAN Foundation joined the Medicare Access for Patients Rx (MAPRx) Coalition and more than 30 patient advocacy organizations to provide recommendations to the Centers for Medicare & Medicaid Services (CMS) on implementation of the Medicare Prescription Payment Plan.